{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:16Z","timestamp":1759403476409,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2020.12.086","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:38:29Z","timestamp":1610930309000},"page":"1140-1147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity, safety and reactogenicity of ROTAVAC\u00ae in healthy infants aged 6\u20138 weeks in Vietnam"],"prefix":"10.1016","volume":"39","author":[{"given":"Nguyen Minh","family":"Hai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Dang","family":"Dung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-8521","authenticated-orcid":false,"given":"Dinh Cong","family":"Pho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Tung","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Ngoc","family":"Hoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phan Tan","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui Dang","family":"The Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"La Huong","family":"Giang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-8001","authenticated-orcid":false,"given":"Pham Ngoc","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.12.086_b0005","unstructured":"Rotarix\u00ae, https:\/\/gskpro.com\/en-us\/products\/rotarix\/#section-34067-9."},{"key":"10.1016\/j.vaccine.2020.12.086_b0010","unstructured":"RotaTeq\u00ae, http:\/\/www.merck.com\/product\/usa\/pi_circulars\/r\/rotateq\/rotateq_pi.pdf."},{"issue":"45","key":"10.1016\/j.vaccine.2020.12.086_b0015","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.086_b0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12889-016-3458-2","article-title":"Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam","volume":"16","author":"Riewpaiboon","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.12.086_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2458-9-29","article-title":"Cost-effectiveness of Rotavirus vaccination in Vietnam","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.086_b0030","first-page":"108","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"28","author":"Madhi","year":"2016","journal-title":"Malawi Med J"},{"issue":"51\u201352","key":"10.1016\/j.vaccine.2020.12.086_b0035","first-page":"533","article-title":"Rotavirus vaccines: an update","volume":"84","author":"Organization","year":"2009","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2020.12.086_b0040","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jinf.2013.09.010","article-title":"Rotavirus vaccines: successes and challenges","volume":"68","author":"Glass","year":"2014","journal-title":"J Infect"},{"issue":"34","key":"10.1016\/j.vaccine.2020.12.086_b0045","doi-asserted-by":"crossref","first-page":"12307","DOI":"10.1073\/pnas.1400473111","article-title":"Vaccines against poverty","volume":"111","author":"MacLennan","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/infdis\/168.2.282","article-title":"Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea","volume":"168","author":"Bhan","year":"1993","journal-title":"J Infect Dis"},{"issue":"9935","key":"10.1016\/j.vaccine.2020.12.086_b0055","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.12.086_b0060","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.vaccine.2014.04.079","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life","volume":"32","author":"Bhandari","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.12.086_b0065","series-title":"12th International rotavirus symposium, Melbourne, Australia","article-title":"Introduction of rotavirus vaccine into the Universal Immunization Program in India","author":"Halder","year":"2016"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.12.086_b0070","doi-asserted-by":"crossref","first-page":"A106","DOI":"10.1016\/j.vaccine.2011.11.091","article-title":"Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam","volume":"30","author":"Shin","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.12.086_b0080","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/21645515.2018.1450709","article-title":"A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC\u00ae, administered simultaneously with or without the buffering agent in healthy infants in India","volume":"14","author":"Ella","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.12.086_b0085","first-page":"A114","article-title":"A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children","volume":"30","author":"Dang","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0090","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","article-title":"Rotaviruses: from pathogenesis to vaccination","volume":"136","author":"Greenberg","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.086_b0095","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JVI.74.5.2323-2332.2000","article-title":"Rotavirus infection induces an increase in intracellular calcium concentration in human intestinal epithelial cells: role in microvillar actin alteration","volume":"74","author":"Brunet","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.086_b0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MPG.0000000000000361","article-title":"Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease","volume":"59","author":"McGrath","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/jix668","article-title":"Quantifying the impact of natural immunity on rotavirus vaccine efficacy estimates: A clinical trial in Dhaka, Bangladesh (PROVIDE) and a simulation study","volume":"217","author":"Rogawski","year":"2018","journal-title":"J Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2020.12.086_b0110","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","article-title":"Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants","volume":"34","author":"Taniuchi","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.vaccine.2013.12.017","article-title":"Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants","volume":"32","author":"Appaiahgari","year":"2014","journal-title":"Vaccine"},{"issue":"9741","key":"10.1016\/j.vaccine.2020.12.086_b0120","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.086_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0000000000000481","article-title":"Rotavirus-specific IgG antibodies from mothers\u2019 serum may inhibit infant immune responses to the pentavalent rotavirus vaccine","volume":"34","author":"Becker-Dreps","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/civ828","article-title":"Prevaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants","volume":"62","author":"Moon","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.086_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150100","article-title":"Association of maternal immunity with rotavirus vaccine immunogenicity in Zambian infants","volume":"11","author":"Chilengi","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0140","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.vaccine.2010.11.087","article-title":"Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?","volume":"29","author":"Chan","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.12.086_b0145","doi-asserted-by":"crossref","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","article-title":"Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants","volume":"32","author":"Rongsen-Chandola","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.086_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/INF.0b013e3182489cac","article-title":"Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants","volume":"31","author":"Vesikari","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0155","doi-asserted-by":"crossref","first-page":"e0127622","DOI":"10.1371\/journal.pone.0127622","article-title":"Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine\u2013a randomized trial","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.12.086_b0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1745-6215-15-256","article-title":"Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial","volume":"15","author":"Rongsen-Chandola","year":"2014","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.086_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiw518","article-title":"Significant correlation between the infant gut microbiome and rotavirus vaccine response in Rural Ghana","volume":"215","author":"Harris","year":"2017","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.12.086_b0170","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/INF.0000000000002485","article-title":"Enteropathogens and rotavirus vaccine immunogenicity in a cluster randomized trial of improved water, sanitation and hygiene in rural zimbabwe","volume":"38","author":"Church","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cid\/ciy896","article-title":"Diarrheal etiology and impact of coinfections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India","volume":"69","author":"Praharaj","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chom.2018.07.005","article-title":"Effect of antibiotic-mediated microbiome modulation on rotavirus vaccine immunogenicity: A human, randomized-control proof-of-concept trial","volume":"24","author":"Harris","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0185","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vaccine.2017.07.116","article-title":"The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants","volume":"36","author":"Lazarus","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.086_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/QAD.0000000000001258","article-title":"Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa","volume":"31","author":"Levin","year":"2017","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/INF.0b013e3181f42db9","article-title":"Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa","volume":"30","author":"Steele","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0200","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/infdis\/jix060","article-title":"Inflammation and immune activation in antiretroviral-treated human immunodeficiency virus Type 1-infected african infants and rotavirus vaccine responses","volume":"215","author":"Uprety","year":"2017","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.086_b0205","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiy573","article-title":"Rotavirus vaccine take in infants is associated with secretor status","volume":"219","author":"Armah","year":"2019","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.086_b0210","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/infdis\/jix028","article-title":"Secretor and salivary ABO blood group antigen status predict rotavirus vaccine take in infants","volume":"215","author":"Kazi","year":"2017","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.12.086_b0215","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.12.086_b0220","doi-asserted-by":"crossref","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","article-title":"Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants","volume":"32","author":"Rongsen-Chandola","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.086_b0225","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/21645515.2015.1085143","article-title":"Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants","volume":"12","author":"Li","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"39","key":"10.1016\/j.vaccine.2020.12.086_b0230","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1016\/j.vaccine.2008.08.034","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2010","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.086_b0235","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"49","key":"10.1016\/j.vaccine.2020.12.086_b0240","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1016\/j.vaccine.2019.09.071","article-title":"Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)","volume":"37","author":"Cowley","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.12.086_b0245","doi-asserted-by":"crossref","first-page":"e1003005","DOI":"10.1371\/journal.pmed.1003005","article-title":"Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries","volume":"16","author":"Baker","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.086_b0250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/civ807","article-title":"Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh","volume":"62","author":"Emperador","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.12.086_b0255","doi-asserted-by":"crossref","first-page":"A104","DOI":"10.1016\/j.vaccine.2014.03.036","article-title":"Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India","volume":"32","author":"John","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2020.12.086_b0260","first-page":"906","article-title":"Why was there no vaccine-associated intussusception in Indian rotavirus vaccine trial?","volume":"52","author":"John","year":"2015","journal-title":"Indian Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.086_b0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/INF.0b013e3182421390","article-title":"Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine","volume":"31","author":"Loughlin","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2020.12.086_b0270","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1080\/21645515.2016.1267082","article-title":"Comparison of iatrogenic pain between rotavirus vaccination before and after vaccine injection in 2-month-old infants","volume":"13","author":"Yin","year":"2017","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:23Z","timestamp":1759402403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X21000104"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity, safety and reactogenicity of ROTAVAC\u00ae in healthy infants aged 6\u20138 weeks in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}